| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/20/1991 | EP0412988A1 Fused polycyclic compounds, compositions, methods of manufacture and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 02/20/1991 | CN1049350A Process for preparingnpyrrolo ¾ 2,1-b. thiazole derivatives |
| 02/20/1991 | CN1049337A Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising same |
| 02/19/1991 | WO1991002750A1 Novel inhibitors of thrombin |
| 02/19/1991 | US4994482 Anticoagulants |
| 02/19/1991 | US4994453 Pyrazolopyridine compound and processes for preparation thereof |
| 02/13/1991 | EP0412841A1 Human thrombomodulin derivatives |
| 02/13/1991 | EP0412404A2 Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same |
| 02/13/1991 | EP0412115A1 Hybrid peptides and methods of their use |
| 02/13/1991 | CN1049156A Indenoindole compounds i |
| 02/13/1991 | CN1049106A Stabilized fgf composition and production thereof |
| 02/12/1991 | US4992581 Novel methods of manufacturing thromboxane A2 antagonists |
| 02/12/1991 | US4992469 Method of obtaining an antiplatelet effect |
| 02/12/1991 | US4992282 Stable nutritional vitamin and mineral supplemented beverage |
| 02/12/1991 | CA2022713A1 Human thrombomodulin derivatives |
| 02/12/1991 | CA1280112C Prostaglandin i2 analogue and pharmaceutical containing the same |
| 02/08/1991 | CA2022731A1 Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same |
| 02/06/1991 | EP0411909A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/06/1991 | EP0411908A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/06/1991 | EP0411895A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/06/1991 | EP0411894A2 Azole compounds and their use as transglutaminase inhibitors |
| 02/06/1991 | EP0411833A1 Fibrinogen receptor antagonists |
| 02/06/1991 | EP0411705A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/06/1991 | EP0411701A2 Certain imidazole compounds as transglutaminase inhibitors |
| 02/06/1991 | EP0411678A1 Method for the production of erythropoietin |
| 02/06/1991 | EP0411590A2 Method and preparation for reducing risk of myocardial infarction |
| 02/06/1991 | EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 02/06/1991 | EP0410989A1 Cyclic analogs of atrial natriuretic peptides |
| 02/06/1991 | EP0215050B1 Purification of blood coagulation factor viii by precipitation |
| 02/05/1991 | WO1991001753A1 Inhibition of tumor growth by blockade of the protein c system |
| 02/03/1991 | CA2022422A1 Method and preparation for reducing risk of myocardial infarction |
| 02/01/1991 | CA2022115A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022114A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022112A1 Certain imidazole compounds as transglutaminase inhibitors |
| 02/01/1991 | CA2022111A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/01/1991 | CA2022110A1 Azole compounds and their use as transglutaminase inhibitors |
| 01/30/1991 | EP0410767A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410750A2 Use of Interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia. |
| 01/30/1991 | EP0410541A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410540A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410539A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410537A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410389A1 Indolocarbazol and its use |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0410224A1 Pyrrolo [2,1-b]thiazole derivatives |
| 01/30/1991 | EP0409940A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids. |
| 01/29/1991 | US4988799 Solvent extraction sulfite liquors with amines in water and alcohol, extraction with alkali to precipitate lignosulfonate salts, ion exchanging |
| 01/29/1991 | US4988733 N-[1-(3-phenoxyphenyl)ethyl]acetohydroxamic acid compounds which are useful anti-inflammatory agents |
| 01/29/1991 | US4988707 Pharmacologically active phenylalkanoyl substituted imidazo (4,5-C) pyridines |
| 01/29/1991 | CA2021952A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021951A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021950A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021948A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA1279575C Thiazide diuretics for antihypertension without diuresis |
| 01/24/1991 | WO1991000919A1 Promoters of colony stimulating factor activity |
| 01/24/1991 | DE3923797A1 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-fluoro-prostaglandin derivatives, to processes for their preparation and their pharmaceutical use |
| 01/24/1991 | CA2035861A1 Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0409489A2 Pharmaceuticals |
| 01/23/1991 | EP0409484A2 4,5,6,7-Tetrasubstituted benzoxazolones |
| 01/23/1991 | EP0409410A1 Indenoindole compounds |
| 01/23/1991 | EP0409332A2 Substituted triazoles as angiotensin II antagonists |
| 01/23/1991 | EP0409113A1 Human erythropoietin muteins, their production and their use |
| 01/23/1991 | EP0409052A2 Anticoagulant containing agent |
| 01/23/1991 | EP0409040A1 Antibodies to Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0408933A2 A mutant of pseudomonas, a strain yzh, and a process for producing 851yzh nutrient solution by application of the strain |
| 01/23/1991 | EP0408749A1 Derivatives of 3,18-dihydroxy-9,13-epoxylabdane, method of obtaining them and a hemostatic pharmaceutical preparation based thereon |
| 01/22/1991 | US4987122 Peptide compounds and medical method of use thereof |
| 01/21/1991 | CA2021421A1 4, 5, 6, 7, - tetrasubstituted benzoxazolones |
| 01/20/1991 | CA2021255A1 Substituted triazoles as angiotensin ii antagonists |
| 01/19/1991 | CA2021213A1 Pharmaceuticals |
| 01/18/1991 | WO1991001309A1 Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis |
| 01/18/1991 | CA2036375A1 Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis |
| 01/17/1991 | DE4022010A1 Anticoagulant compsn. for treatment and prophylaxis of thrombosis - contains vascular anti-coagulant protein (annexine) and divalent salt of calcium, cadmium, zinc, manganese or cobalt |
| 01/17/1991 | DE3923798A1 (delta)(pfeil hoch)8(pfeil hoch)-und(delta)(pfeil hoch)9(pfeil hoch)-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung (Delta) (arrow up) 8 (arrow up) -and (delta) (arrow up) 9 (arrow up) -prostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/16/1991 | EP0408371A1 Hemoregulatory peptides |
| 01/16/1991 | EP0407955A1 New hetrazepines acting as PAF antagonists, process for their production and their use as drugs |
| 01/16/1991 | CA2021146A1 Composition comprising an anticoagulant |
| 01/15/1991 | WO1991001303A1 Δ8 and Δ9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE |
| 01/15/1991 | WO1991001302A1 9-fluor-prostaglandine derivates, their process of production and their pharmaceutical use |
| 01/15/1991 | US4985550 Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants |
| 01/15/1991 | US4985448 Ureidoindoles, pharmaceutical compositions and methods for erythrocyte and thrombocyte aggregation inhibition |
| 01/15/1991 | US4985444 Pyrazolopyridine compound and processes for preparation thereof |
| 01/15/1991 | US4985245 tPA-containing medical composition |
| 01/15/1991 | CA2036386A1 9-fluoroprostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/15/1991 | CA2036383A1 8-and 9-prostaglandin derivatives, process for their production and their pharmaceutical use |
| 01/14/1991 | CA2021135A1 Pyrrolo[2,1-b]thiazole derivatives |
| 01/13/1991 | CA2020806A1 Thienodiazepine derivatives |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000110A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 01/10/1991 | WO1990012874A3 Cysteine added variants of polypeptides and chemical modifications thereof |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0406856A2 Stabilized FGF composition and production thereof |
| 01/09/1991 | EP0406428A1 Peptide derivatives and their use |
| 01/09/1991 | EP0406369A1 Virus inactivated blood product and method |
| 01/08/1991 | US4983592 Bis-arylphosphate ester antagonists of platelet activating factor |
| 01/08/1991 | CA2020654A1 Stabilized fgf composition and production thereof |
| 01/02/1991 | EP0406216A2 Protein-S-containing pharmaceutical preparation |
| 01/02/1991 | EP0405864A2 Phospholipase A2 inhibitor, microorganisms producing said inhibitor and processes for its production |
| 01/02/1991 | EP0405484A1 A physiologically active substance derived of malt and process for the production thereof |
| 01/02/1991 | EP0405442A1 4,5-Dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid derivatives |